Skip to main content
. Author manuscript; available in PMC: 2017 Mar 7.
Published in final edited form as: Arthritis Rheumatol. 2015 Mar;67(3):761–772. doi: 10.1002/art.38983

Table 2.

Crude and adjusted odds ratios for dichotomous ESRD quality-of-care indicators (pre-ESRD care, knowledge of transplant options, and permanent hemodialysis vascular access) by sociodemographic factor, among US patients in whom treatment for ESRD attributed to lupus nephritis was initiated between July 1, 2005 and September 30, 2011*

Patient received pre-ESRD nephrology care Patient informed of transplant options Fistula/graft used or in place at first dialysis



Crude % Odds ratio (95% CI) Crude % Odds ratio (95% CI) Crude % Odds ratio (95% CI)



Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted
Overall 71.1 84.8 24.4
Individual sociodemographic factors
 Race/ethnicity, %
  White 76.7 1.00 (ref.) 1.00 (ref.) 84.0 1.00 (ref.) 1.00 (ref.) 28.2 1.00 (ref.) 1.00 (ref.)
  Black 69.1 0.68 (0.59–0.79) 0.73 (0.63–0.85) 85.4 1.21 (0.99–1.48) 1.07 (0.88–1.30) 24.1 0.81 (0.70–0.94) 0.96 (0.81–1.12)
  Hispanic 67.1 0.61 (0.52–0.73) 0.73 (0.60–0.88) 83.9 1.02 (0.80–1.31) 0.95 (0.75–1.20) 20.5 0.65 (0.54–0.80) 0.85 (0.69–1.05)
  Other 74.8 0.90 (0.70–1.14) 0.95 (0.74–1.22) 84.8 1.15 (0.83–1.61) 0.99 (0.72–1.35) 24.4 0.83 (0.64–1.07) 1.06 (0.81–1.38)
 Insurance, %
  Private 78.4 1.00 (ref.) 1.00 (ref.) 87.6 1.00 (ref.) 1.00 (ref.) 25.3 1.00 (ref.) 1.00 (ref.)
  Medicare/other 73.4 0.77 (0.65–0.91) 0.76 (0.63–0.90) 82.8 0.66 (0.51–0.85) 0.61 (0.47–0.80) 28.5 1.18 (0.99–1.10) 1.03 (0.86–1.23)
  Medicaid 69.3 0.62 (0.54–0.72) 0.64 (0.56–0.74) 83.4 0.71 (0.59–0.87) 0.66 (0.54–0.80) 24.4 0.95 (0.82–1.10) 1.05 (0.91–1.22)
  None 47.5 0.25 (0.21–0.30) 0.26 (0.21–0.31) 83.4 0.65 (0.51–0.83) 0.68 (0.54–0.87) 16.0 0.55 (0.43–0.69) 0.62 (0.49–0.79)
Residential neighborhood (ZCTA) sociodemographic factors§
 % black
  Below median 73.4 1.00 (ref.) 1.00 (ref.) 84.2 1.00 (ref.) 1.00 (ref.) 24.6 1.00 (ref.) 1.00 (ref.)
  Above median 68.9 0.81 (0.72–0.91) 0.95 (0.82–1.09) 85.4 1.09 (0.94–1.26) 1.04 (0.87–1.25) 24.2 0.97 (0.86–1.10) 1.01 (0.86–1.18)
 % Hispanic
  Below median 73.4 1.00 (ref.) 1.00 (ref.) 84.5 1.00 (ref.) 1.00 (ref.) 25.2 1.00 (ref.) 1.00 (ref.)
  Above median 68.9 0.81 (0.72–0.91) 0.83 (0.73–0.95) 85.2 1.06 (0.91–1.23) 1.05 (0.91–1.23) 23.6 0.92 (0.81–1.04) 0.99 (0.87–1.12)
 % dropped out of high school
  Below median 74.0 1.00 (ref.) 1.00 (ref.) 85.8 1.00 (ref.) 1.00 (ref.) 25.0 1.00 (ref.) 1.00 (ref.)
  Above median 68.3 0.76 (0.68–0.85) 0.89 (0.79–1.01) 83.9 0.85 (0.73–0.98) 0.87 (0.74–1.02) 23.9 0.93 (0.83–1.06) 1.01 (0.88–1.15)
 % with income below poverty level
  Below median 74.6 1.00 (ref.) 1.00 (ref.) 85.3 1.00 (ref.) 1.00 (ref.) 25.9 1.00 (ref.) 1.00 (ref.)
  Above median 67.7 0.72 (0.64–0.81) 0.84 (0.74–0.95) 84.3 0.91 (0.79–1.06) 0.93 (0.79–1.09) 23.0 0.85 (0.75–0.96) 0.88 (0.77–1.00)
*

Adjusted models (complete case analysis) include age, race/ethnicity, insurance, body mass index (≥35 kg/m2 versus <35 kg/m2), hypertension, and cardiovascular disease. ref. = referent; ZCTA = ZIP code tabulation area.

Numbers of patients in the assessment of crude percent and in the assessment of odds ratio (95% confidence interval [95% CI]), respectively, were 5,939 and 5,875 for pre–end-stage renal disease (pre-ESRD) nephrology care, 5,619 and 5,558 for patient informed of transplant options, and 5,624 and 5,562 for fistula/graft used or in place at first dialysis.

Includes Medicare, VA, and other.

§

Numbers of patients in the assessment of crude percent and in the assessment of odds ratio (95% CI), respectively, were 5,810 and 5,746 for pre-ESRD nephrology care, 5,492 and 5,431 for patient informed of transplant options, and 5,500 and 5,438 for fistula/graft used or in place at first dialysis.